C WorldWide Group Holding A/S - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.

Quarter-by-quarter ownership
C WorldWide Group Holding A/S ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,255,000
-56.4%
18,102
-52.5%
0.02%
-60.0%
Q2 2018$2,880,000
+76.7%
38,070
+23.1%
0.04%
+60.0%
Q1 2018$1,630,000
-16.0%
30,929
-14.9%
0.02%
-10.7%
Q4 2017$1,941,000
-49.2%
36,327
-43.3%
0.03%
-48.1%
Q3 2017$3,819,000
-0.7%
64,042
+31.4%
0.05%
-6.9%
Q2 2017$3,845,000
-28.8%
48,741
-25.1%
0.06%
-36.3%
Q1 2017$5,398,000
+26.9%
65,085
+21.4%
0.09%
+11.0%
Q4 2016$4,253,000
-27.1%
53,600
-35.7%
0.08%
-20.4%
Q3 2016$5,838,000
+54.5%
83,407
-14.4%
0.10%
+43.1%
Q2 2016$3,778,000
-53.1%
97,407
-51.0%
0.07%
-53.8%
Q1 2016$8,056,000
-58.5%
198,907
-9.1%
0.16%
-54.1%
Q4 2015$19,410,000
-4.3%
218,907
-20.1%
0.34%
-0.3%
Q3 2015$20,277,000
-55.1%
273,907
-51.0%
0.34%
+5.6%
Q2 2015$45,186,000
+702.6%
558,814
+315.8%
0.32%
+303.8%
Q1 2015$5,630,000
+284.8%
134,407
+42.4%
0.08%
+263.6%
Q4 2014$1,463,000
-14.7%
94,407
-32.6%
0.02%
-12.0%
Q3 2014$1,715,000140,0000.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders